Pre-Open Movers

HealthEquity (NASDAQ: HQY) 14% HIGHER; reported Q3 EPS of $0.47, $0.25 better than the analyst estimate of $0.22. Revenue for the quarter came in at $157.1 million versus the consensus estimate of $152.38 million. HealthEquity sees FY2020 EPS of $1.46-$1.52, versus the consensus of $1.28. HealthEquity sees FY2020 revenue of $520-526 million, versus the consensus of $517.31 million.

Chesapeake Energy Corporation (NYSE: CHK) 12% HIGHER; announced today that it has engaged JPMorgan Chase Bank, N.A., Morgan Stanley Bank, N.A., Bank of America, N.A. and MUFG Bank, N.A. to assist with the arrangement of a secured first lien last out 4.5-year term loan facility in the aggregate principal amount of up to $1.5 billion.

Revance Therapeutics, Inc. (Nasdaq: RVNC) 10.7% LOWER; announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a price to the public of $17.00 per share.

Lannett Company, Inc. (NYSE: LCI) 10% HIGHER; announced positive results from the first human study evaluating insulin glargine that Lannett is developing with its strategic alliance partners within the HEC Group of companies (HEC). Insulin glargine is a long-acting insulin used to treat adults with Type 2 diabetes, as well as adults and pediatric patients with Type 1 diabetes, for the control of high blood sugar.

Relmada Therapeutics, Inc. (Nasdaq: RLMD) 8.5% LOWER; announced its intention to offer and sell shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement. Relmada also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the size or terms of the offering.

RAPT Therapeutics, Inc. (Nasdaq: RAPT) 8.2% HIGHER; The company and Hanmi Pharmaceutical Co., LTD today announced a license and collaboration agreement for FLX475 in Asia. FLX475 is an oral, small molecule CCR4 antagonist in development for the treatment of multiple cancers.

Immunomedics, Inc. (NASDAQ: IMMU) 7.4% LOWER; announced it has commenced an underwritten public offering of $250,000,000 of shares of its common stock. In addition, Immunomedics expects to grant the underwriters a 30-day option to purchase up to an aggregate of an additional $37,500,000 of shares of common stock sold in connection with the offering at the public offering price.

Frontier Communications Corporation (NASDAQ: FTR) 6.8% HIGHER; announced today that the Companys Board of Directors has unanimously appointed Bernard L. Bernie Han as President and Chief Executive Officer and a member of the Board, effective immediately. Mr. Han succeeds Daniel McCarthy, who is stepping down as President and Chief Executive Officer and from his position on the Board.

Adamas Pharma (NASDAQ: ADMS) 6.5% LOWER; filed a prospectus covering $50 million in common stock. Shares will be offered through Cowen.

Expedia Group, Inc. (NASDAQ: EXPE) 5.1% HIGHER; announced the resignation of Mark Okerstrom as CEO and a member of the Board of Directors and CFO Alan Pickerill, effective immediately.

Zscaler (NASDAQ: ZS) 5.1% LOWER; reported Q1 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $89.79 million.

Dynatrace, Inc. (NYSE: DT) 3.8% LOWER; announced today the commencement of an underwritten public offering of 27,500,000 shares of common stock by certain selling stockholders of Dynatrace.

GoPro, Inc. (NASDAQ: GPRO) 3.1% HIGHER; announced a strong Black Friday and Cyber Monday shopping period. The Company reported year-over-year sell-through growth of 30% based on available data from its larger U.S. retail partners and 20% based on available data from its European retail partners during the Black Friday week. In addition, GoPro.com achieved more than 120% year-over-year growth in total camera unit sales during the entire Black Friday / Cyber Monday period, where HERO8 Black sold at record levels, comprising more than 90% of total sales.

MasterCard (NYSE: MA) 1% HIGHER; declared a quarterly dividend of $0.40 per share, or $1.6 annualized. This is a 21.2% increase from the prior dividend of $0.33. The Board of Directors also approved a new share repurchase program, authorizing the company to repurchase up to $8 billion of its Class A common stock.